Category: Smith & Nephew
A recent spate of mega-mergers hasn't inspired medtech peers to follow suit just yet, according to leadership at Boston Scientific, C.R. Bard and Smith & Nephew.
The medical device industry has some blockbuster merger activity in recent months, but a few companies are sitting this one out.
Smith & Nephew CEO Olivier Bohuon reveals a new, 'no frills' strategy for developed markets that the company 1st pioneered in emerging markets.
Smith & Nephew integrates its partial knee implants with Blue Belt Technologies' Navio robot-assisted surgical system.
Kinetic Concepts Inc. agrees to a $280-million settlement of its long-running patent infringement war with Wake Forest University over negative-pressure wound therapy technology.
UPDATED July 1, 2014, with comment from KCI.
Kinetic Concepts Inc. said it agreed to pay $280 million to settle a patent infringement lawsuit with Wake Forest University, putting their long-running war over negative-pressure wound therapy to rest.
Smith & Nephew stops selling its Renasys negative pressure wound therapy product in the U.S. after the FDA says the company needs new regulatory clearance.
Medtronic stays mum about media speculation that it might be in the hunt for British orthopedics giant Smith & Nephew.
Here's a look at some of the top Wall Street stories for medical device companies this week: What if Stryker bought Smith & Nephew?; Allergan proxy war gets ugly as Valeant aims to unseat the board; Report: Is Medtronic looking to buy Smith & Nephew?
Stryker CEO Kevin Lobo yesterday admitted that his company was evaluating an acquisition of British orthopedics rival Smith & Nephew.